glp-1 mounjaro use tripled among non-diabetics, reaching $5.8B in 2022 Can GLP-1 Medications Like Ozempic

In animal models, exenatide and liraglutide delay disease onset, reduce severity, and promote remyelination by shifting microglia and macrophages from pro-inflammatory to anti-inflammatory phenotypes, lowering cytokine levels [[39], [40], [41]]

*Correspondence: R

Tumor necrosis factor alfa (TNF-) (6.1 (5.3

Faurschou, A

The study is among the first large-scale analyses to identify a significant association between GLP-1 receptor agonist use and reduced risk of legal blindness in a high-risk diabetic population

Results A reduction in GLP-1 expression was observed in DIO mice with mitochondrial stress responses in the colon enterocytes